| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9954930 | International Immunopharmacology | 2018 | 10 Pages |
Abstract
These results illustrate the importance of MDSCs in immunotherapy resistance and provide evidence that targeting MDSCs in cancer patients may augment immunotherapeutic approaches.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Richard P. Tobin, Kimberly R. Jordan, William A. Robinson, Dana Davis, Virginia F. Borges, Rene Gonzalez, Karl D. Lewis, Martin D. McCarter,